D
Dragon Pharma
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tesamorelin | X | 1 | 5.8 | 5.8 | 5.8 | 24 Jul 2025 |
| Anadrol (Oxymetholone) | X | 1 | 4.7 | 4.7 | 4.7 | 3 Jul 2025 |
| Blend 300 (TRA/Mast P/Test P) | X | 1 | 4.4 | 4.4 | 4.4 | 7 May 2025 |
| Boldenone Undecylenate (EQ) Raw | X | 1 | 5.3 | 5.3 | 5.3 | 13 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X | 1 | 8.7 | 8.7 | 8.7 | 24 Apr 2025 |
| Cerebrolysin | X | 1 | 5.5 | 5.5 | 5.5 | 16 Mar 2025 |
| Deca (Nandrolone Decanoate) | X | 1 | 5.7 | 5.7 | 5.7 | 20 Jun 2025 |
| Dianabol | X | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 |
| Drostanolone Enanthate (Mast E) Raw | X | 1 | 6.6 | 6.6 | 6.6 | 7 May 2025 |
| Enclomiphene | X | 1 | 4.0 | 3.7 | 3.7 | 2 Apr 2025 |
| Epithalon | X | 1 | 6.3 | 6.3 | 6.3 | 9 Jun 2025 |
| EPO | X | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 |
| Equipoise (Boldenone Undecylenate) | X | 1 | 6.5 | 6.5 | 6.5 | 13 Feb 2025 |
| GHRP-2 Acetate | X | 1 | 4.0 | 3.9 | 3.9 | 6 May 2025 |
| Hyaluronic acid | X | 1 | 4.0 | 3.0 | 3.0 | 3 Jun 2025 |
| Ivermectin | X | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| KPV Oral | X | 1 | 4.0 | 3.9 | 3.9 | 27 Feb 2025 |
| L-Carnitine 500mg | X | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| LGD-4033 (Ligandrol) | X | 1 | 4.8 | 4.8 | 4.8 | 2 Apr 2025 |
| MGF | X | 1 | 7.8 | 7.8 | 7.8 | 11 Jun 2025 |
| MOTS-C | X | 1 | 5.9 | 5.9 | 5.9 | 27 Feb 2025 |
| MT-1 | X | 1 | 7.1 | 7.1 | 7.1 | 3 Jun 2025 |
| NA Selank Amidate | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 |
| NA Semax Amidate | X | 1 | 5.7 | 5.7 | 5.7 | 14 Jan 2025 |
| NAD+ | X | 1 | 6.3 | 6.3 | 6.3 | 3 Jun 2025 |
| Ovagen | X | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| Oxytocin Acetate | X | 1 | 7.0 | 7.0 | 7.0 | 11 Jun 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X | 1 | 7.6 | 7.6 | 7.6 | 25 Apr 2025 |
| Pancragen | X | 1 | 4.7 | 4.7 | 4.7 | 7 May 2025 |
| Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | X | 1 | 4.9 | 4.9 | 4.9 | 27 Feb 2025 |
| Retatrutide 30mg Pen Kit | X | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 |
| Selank | X | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 |
| Semax | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 |
| Telmisartan | X | 1 | 4.2 | 4.2 | 4.2 | 6 May 2025 |
| Test Suspension | X | 1 | 4.8 | 4.8 | 4.8 | 28 Mar 2025 |
| Testosterone Propionate Raw | X | 1 | 6.0 | 6.0 | 6.0 | 27 Feb 2025 |
| Vilon | X | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Anadrol (Oxymetholone) | 4.0 | 25mg | 31.0mg | +24.0% | 99.14% | Lab A |
| 25 May 2026 | Vilon | 8.3 | 30mg | 29.7mg | -1.0% | 95.64% | Lab D |
| 24 May 2026 | KPV Oral | 4.3 | 20mg | 18.0mg | -10.2% | 99.02% | Lab A |
| 24 May 2026 | MGF | 9.7 | 20mg | 18.2mg | -8.9% | 95.34% | Lab F |
| 24 May 2026 | L-Carnitine 500mg | 4.7 | 250mg/ml | 278.4mg/ml | +11.4% | 96.53% | Lab C |
| 24 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 5.4 | 100mg/ml | 93.5mg/ml | -6.5% | 97.07% | Lab F |
| 24 May 2026 | Selank | 4.0 | 50mg | 51.5mg | +3.0% | 95.63% | Lab C |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 4.9 | 200mg/ml | 236.7mg/ml | +18.3% | 99.97% | Lab C |
| 24 May 2026 | NAD+ | 7.5 | 10mg | 9.6mg | -4.3% | 98.50% | Lab C |
| 23 May 2026 | Ovagen | 4.7 | 10mg | 12.4mg | +24.0% | 98.32% | Lab F |
| 21 May 2026 | Enclomiphene | 4.9 | 20mg | 17.1mg | -14.3% | 98.83% | Lab F |
| 21 May 2026 | Ivermectin | 5.9 | 100mg | 119.1mg | +19.1% | 98.22% | Lab F |
| 21 May 2026 | MT-1 | 9.6 | 50mg | 53.3mg | +6.7% | 96.33% | Lab E |
| 21 May 2026 | NA Selank Amidate | 9.0 | 30mg | 31.0mg | +3.5% | 95.22% | Lab C |
| 21 May 2026 | Semax | 4.3 | 10mg | 11.1mg | +11.3% | 95.75% | Lab B |
| 20 May 2026 | Hyaluronic acid | 5.0 | 20mg | 24.4mg | +21.9% | 96.04% | Lab F |
| 20 May 2026 | Pancragen | 4.4 | 50mg | 57.1mg | +14.2% | 95.63% | Lab A |
| 17 May 2026 | Epithalon | 5.9 | 20mg | 21.3mg | +6.4% | 95.68% | Lab B |
| 29 Jan 2026 | EPO | 5.2 | 20mg | 23.2mg | +16.0% | 97.14% | Lab B |
| 29 Jan 2026 | GHRP-2 Acetate | 4.3 | 20mg | 19.7mg | -1.7% | 98.17% | Lab A |
| 26 Jan 2026 | Retatrutide 30mg Pen Kit | 6.9 | 2mg | 2.1mg | +7.2% | 95.79% | Lab B |
| 26 Jan 2026 | Test Suspension | 4.7 | 250mg/ml | 291.1mg/ml | +16.4% | 95.05% | Lab B |
| 9 Jan 2026 | Boldenone Undecylenate (EQ) Raw | 5.4 | 10g | 10.9g | +8.9% | 95.06% | Lab A |
| 9 Jan 2026 | Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | 5.5 | 10g | 12.5g | +25.0% | 98.64% | Lab E |
| 7 Jan 2026 | Cerebrolysin | 4.0 | 15mg | 17.0mg | +13.1% | 95.23% | Lab B |
| 6 Jan 2026 | LGD-4033 (Ligandrol) | 6.5 | 50mg | 44.3mg | -11.4% | 98.20% | Lab D |
| 6 Jan 2026 | MOTS-C | 8.0 | 2mg | 2.0mg | -1.6% | 98.79% | Lab G |
| 29 Dec 2025 | Dianabol | 7.5 | 10mg | 12.0mg | +20.3% | 95.04% | Lab E |
| 29 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.3 | 2mg | 2.0mg | +1.2% | 95.92% | Lab A |
| 12 Dec 2025 | Deca (Nandrolone Decanoate) | 4.0 | 200mg/ml | 172.3mg/ml | -13.8% | 96.14% | Lab D |
| 12 Dec 2025 | Equipoise (Boldenone Undecylenate) | 6.6 | 250mg/ml | 271.3mg/ml | +8.5% | 97.28% | Lab F |
| 23 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 5.8 | 100g | 118.9g | +18.9% | 95.65% | Lab B |
| 17 Nov 2025 | Telmisartan | 4.0 | 25mg | 26.4mg | +5.8% | 98.75% | Lab G |
| 17 Oct 2025 | NA Semax Amidate | 4.4 | 2mg | 2.4mg | +21.7% | 98.48% | Lab B |
| 17 Oct 2025 | Testosterone Propionate Raw | 8.6 | 500g | 608.8g | +21.8% | 96.79% | Lab A |
| 9 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 9.1 | 2mg | 2.5mg | +23.5% | 98.33% | Lab D |
| 9 Oct 2025 | Oxytocin Acetate | 7.7 | 50mg | 51.8mg | +3.5% | 99.65% | Lab F |
| 9 Oct 2025 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 6.0 | 5g | 5.3g | +7.0% | 99.65% | Lab B |
| 24 Jul 2025 | Tesamorelin | 5.8 | 5mg | 4.7mg | -6.0% | 99.06% | Lab A |